APO RESEARCH · REPORT
Tylosin
Tylosin is a macrolide-class broad spectrum antibiotic that’s used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
Product & engineering
Understand the product.
Tylosin is a macrolide-class broad spectrum antibiotic that’s used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
Selected research
Market Outlook & Growth Opportunities
Global Tylosin Market Outlook and Growth Opportunities 2026
Market perspective
Tylosin is a macrolide-class broad spectrum antibiotic that’s used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
Elanco, Huvepharma, Tairui, Lukang Shelile and Qilu Pharmaceutical are the main players in this industry. Tairui was considered the leader of the global market, accounting for 43% of the sales volume.
The global Tylosin market is led by Asia Pacific. Europe is the second-largest region-wise market.
Read the full market overview
This report provides an overview of the global Tylosin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tylosin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tylosin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tylosin market size, projected growth trends, production technologies, key applications, and end-use industries.
Tylosin Segment by Company
Elanco
Huvepharma
Tairui
Lukang Shelile
Qilu Pharmaceutical
Top Pharm Chemical Group
HISUN
Apeloa
Tylosin Segment by Type
Tylosin Tartrate
Tylosin Phosphate
Tylosin Segment by Application
Animal Feed Additives
Animal Drugs
Tylosin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Tylosin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Tylosin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Tylosin significant trends, drivers, influence factors in global and regions.
6. To analyze Tylosin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tylosin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tylosin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tylosin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tylosin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tylosin industry.
Chapter 3: Detailed analysis of Tylosin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Tylosin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Tylosin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Tylosin Tartrate
- Tylosin Phosphate
Applications
- Animal Feed Additives
- Animal Drugs
Companies covered
- Elanco
- Huvepharma
- Tairui
- Lukang Shelile
- Qilu Pharmaceutical
- Top Pharm Chemical Group
- HISUN
- Apeloa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tylosin Sales Value (2021-2032)
- 1.2.2 Global Tylosin Sales Volume (2021-2032)
- 1.2.3 Global Tylosin Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Tylosin Market Dynamics
- 2.1 Tylosin Industry Trends
- 2.2 Tylosin Industry Drivers
- 2.3 Tylosin Industry Opportunities and Challenges
- 2.4 Tylosin Industry Restraints
3 Tylosin Market by Company
- 3.1 Global Tylosin Company Revenue Ranking in 2025
- 3.2 Global Tylosin Revenue by Company (2021-2026)
- 3.3 Global Tylosin Sales Volume by Company (2021-2026)
- 3.4 Global Tylosin Average Price by Company (2021-2026)
- 3.5 Global Tylosin Company Ranking (2024-2026)
- 3.6 Global Tylosin Company Manufacturing Base and Headquarters
- 3.7 Global Tylosin Company Product Type and Application
- 3.8 Global Tylosin Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Tylosin Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Tylosin Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Tylosin Market by Type
- 4.1 Tylosin Type Introduction
- 4.1.1 Tylosin Tartrate
- 4.1.2 Tylosin Phosphate
- 4.2 Global Tylosin Sales Volume by Type
- 4.2.1 Global Tylosin Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tylosin Sales Volume by Type (2021-2032)
- 4.2.3 Global Tylosin Sales Volume Share by Type (2021-2032)
- 4.3 Global Tylosin Sales Value by Type
- 4.3.1 Global Tylosin Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tylosin Sales Value by Type (2021-2032)
- 4.3.3 Global Tylosin Sales Value Share by Type (2021-2032)
5 Tylosin Market by Application
- 5.1 Tylosin Application Introduction
- 5.1.1 Animal Feed Additives
- 5.1.2 Animal Drugs
- 5.2 Global Tylosin Sales Volume by Application
- 5.2.1 Global Tylosin Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tylosin Sales Volume by Application (2021-2032)
- 5.2.3 Global Tylosin Sales Volume Share by Application (2021-2032)
- 5.3 Global Tylosin Sales Value by Application
- 5.3.1 Global Tylosin Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tylosin Sales Value by Application (2021-2032)
- 5.3.3 Global Tylosin Sales Value Share by Application (2021-2032)
6 Tylosin Regional Sales and Value Analysis
- 6.1 Global Tylosin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tylosin Sales by Region (2021-2032)
- 6.2.1 Global Tylosin Sales by Region: 2021-2026
- 6.2.2 Global Tylosin Sales by Region (2027-2032)
- 6.3 Global Tylosin Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Tylosin Sales Value by Region (2021-2032)
- 6.4.1 Global Tylosin Sales Value by Region: 2021-2026
- 6.4.2 Global Tylosin Sales Value by Region (2027-2032)
- 6.5 Global Tylosin Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Tylosin Sales Value (2021-2032)
- 6.6.2 North America Tylosin Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Tylosin Sales Value (2021-2032)
- 6.7.2 Europe Tylosin Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Tylosin Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Tylosin Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Tylosin Sales Value (2021-2032)
- 6.9.2 South America Tylosin Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Tylosin Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Tylosin Sales Value Share by Country, 2025 VS 2032
7 Tylosin Country-level Sales and Value Analysis
- 7.1 Global Tylosin Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Tylosin Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Tylosin Sales by Country (2021-2032)
- 7.3.1 Global Tylosin Sales by Country (2021-2026)
- 7.3.2 Global Tylosin Sales by Country (2027-2032)
- 7.4 Global Tylosin Sales Value by Country (2021-2032)
- 7.4.1 Global Tylosin Sales Value by Country (2021-2026)
- 7.4.2 Global Tylosin Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Tylosin Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Tylosin Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Tylosin Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Tylosin Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Tylosin Sales Value Growth Rate (2021-2032)
- 7.9.2 France Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Tylosin Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Tylosin Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Tylosin Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Tylosin Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Tylosin Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Tylosin Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Tylosin Sales Value Growth Rate (2021-2032)
- 7.16.2 China Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Tylosin Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Tylosin Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Tylosin Sales Value Growth Rate (2021-2032)
- 7.19.2 India Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Tylosin Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Tylosin Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Tylosin Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Tylosin Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Tylosin Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Tylosin Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Tylosin Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Tylosin Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Tylosin Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Tylosin Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Tylosin Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Tylosin Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Tylosin Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Tylosin Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Tylosin Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Tylosin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Elanco
- 8.1.1 Elanco Company Information
- 8.1.2 Elanco Business Overview
- 8.1.3 Elanco Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Elanco Tylosin Product Portfolio
- 8.1.5 Elanco Recent Developments
- 8.2 Huvepharma
- 8.2.1 Huvepharma Company Information
- 8.2.2 Huvepharma Business Overview
- 8.2.3 Huvepharma Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Huvepharma Tylosin Product Portfolio
- 8.2.5 Huvepharma Recent Developments
- 8.3 Tairui
- 8.3.1 Tairui Company Information
- 8.3.2 Tairui Business Overview
- 8.3.3 Tairui Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Tairui Tylosin Product Portfolio
- 8.3.5 Tairui Recent Developments
- 8.4 Lukang Shelile
- 8.4.1 Lukang Shelile Company Information
- 8.4.2 Lukang Shelile Business Overview
- 8.4.3 Lukang Shelile Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Lukang Shelile Tylosin Product Portfolio
- 8.4.5 Lukang Shelile Recent Developments
- 8.5 Qilu Pharmaceutical
- 8.5.1 Qilu Pharmaceutical Company Information
- 8.5.2 Qilu Pharmaceutical Business Overview
- 8.5.3 Qilu Pharmaceutical Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Qilu Pharmaceutical Tylosin Product Portfolio
- 8.5.5 Qilu Pharmaceutical Recent Developments
- 8.6 Top Pharm Chemical Group
- 8.6.1 Top Pharm Chemical Group Company Information
- 8.6.2 Top Pharm Chemical Group Business Overview
- 8.6.3 Top Pharm Chemical Group Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Top Pharm Chemical Group Tylosin Product Portfolio
- 8.6.5 Top Pharm Chemical Group Recent Developments
- 8.7 HISUN
- 8.7.1 HISUN Company Information
- 8.7.2 HISUN Business Overview
- 8.7.3 HISUN Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.7.4 HISUN Tylosin Product Portfolio
- 8.7.5 HISUN Recent Developments
- 8.8 Apeloa
- 8.8.1 Apeloa Company Information
- 8.8.2 Apeloa Business Overview
- 8.8.3 Apeloa Tylosin Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Apeloa Tylosin Product Portfolio
- 8.8.5 Apeloa Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Tylosin Value Chain Analysis
- 9.1.1 Tylosin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tylosin Sales Mode & Process
- 9.2 Tylosin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tylosin Distributors
- 9.2.3 Tylosin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst